Trial · NCT04820530
Adverse events17
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 17 of 17
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal pain | Gastrointestinal disorders | LNP023 200mg b.i.d. | 3 | 40 | |
| other | Constipation | Gastrointestinal disorders | LNP023 200mg b.i.d. | 3 | 40 | |
| other | Diarrhoea | Gastrointestinal disorders | LNP023 200mg b.i.d. | 6 | 40 | |
| other | Vomiting | Gastrointestinal disorders | LNP023 200mg b.i.d. | 3 | 40 | |
| other | Pyrexia | General disorders | LNP023 200mg b.i.d. | 3 | 40 | |
| other | COVID-19 | Infections and infestations | LNP023 200mg b.i.d. | 7 | 40 | |
| other | Upper respiratory tract infection | Infections and infestations | LNP023 200mg b.i.d. | 7 | 40 | |
| other | Iron deficiency | Metabolism and nutrition disorders | LNP023 200mg b.i.d. | 3 | 40 | |
| other | Headache | Nervous system disorders | LNP023 200mg b.i.d. | 12 | 40 | |
| serious | Breakthrough haemolysis | Blood and lymphatic system disorders | LNP023 200mg b.i.d. | 1 | 40 | |
| serious | Cataract | Eye disorders | LNP023 200mg b.i.d. | 1 | 40 | |
| serious | COVID-19 | Infections and infestations | LNP023 200mg b.i.d. | 2 | 40 | |
| serious | Infection | Infections and infestations | LNP023 200mg b.i.d. | 1 | 40 | |
| serious | Pneumonia | Infections and infestations | LNP023 200mg b.i.d. | 1 | 40 | |
| serious | Pneumonia bacterial | Infections and infestations | LNP023 200mg b.i.d. | 1 | 40 | |
| serious | Type 2 diabetes mellitus | Metabolism and nutrition disorders | LNP023 200mg b.i.d. | 1 | 40 | |
| serious | Malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | LNP023 200mg b.i.d. | 1 | 40 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04820530/events